v3.26.1
Condensed Consolidated Statement of Stockholders' Deficit, Unaudited - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2024 $ 428,425 $ 121,173,575 $ (127,300,000) $ (5,698,000)
Beginning balance, shares at Dec. 31, 2024 428,424,880      
Common stock issued on conversion of notes payable $ 62,805 2,168,195 2,231,000
Common stock issued on conversion of notes payable, shares 62,804,832      
Relative fair value of warrants issued with convertible notes 1,430,000 1,430,000
Common stock issued upon exercise of stock options and warrants $ 15,419 711,581 727,000
Common stock issued upon exercise of stock options and warrants, shares 15,418,805      
Common stock issued upon cashless exercise of warrants to settle vendor payables $ 2,017 96,983 99,000
Common stock issued upon cashless exercise of warrants to settle vendor payables, shares 2,016,660      
Fair value of vested stock options and warrants 6,740,000 6,740,000
Stock-based compensation expense – warrant modification   511,000   511,000
Fair value of common stock issued for services $ 9,050 1,441,950 1,451,000
Fair value of common stock issued for services, shares 9,050,000      
Fair value of common stock issued as compensation $ 1,500 238,500 240,000
Fair value of common stock issued as compensation, shares 1,500,000      
Net loss (11,813,000) (11,813,000)
Ending balance, value at Jun. 30, 2025 $ 519,216 134,511,784 (139,113,000) (4,082,000)
Ending balance, shares at Jun. 30, 2025 519,215,177      
Beginning balance, value at Mar. 31, 2025 $ 483,744 132,143,256 (136,974,000) (4,347,000)
Beginning balance, shares at Mar. 31, 2025 483,744,622      
Common stock issued on conversion of notes payable $ 22,527 560,473 583,000
Common stock issued on conversion of notes payable, shares 22,526,487      
Relative fair value of warrants issued with convertible notes 632,000 632,000
Common stock issued upon exercise of stock options and warrants $ 12,328 498,672 511,000
Common stock issued upon exercise of stock options and warrants, shares 12,327,405      
Common stock issued upon cashless exercise of warrants to settle vendor payables $ 367 27,633 28,000
Common stock issued upon cashless exercise of warrants to settle vendor payables, shares 366,663      
Fair value of vested stock options and warrants 91,000 91,000
Stock-based compensation expense – warrant modification 511,000 511,000
Fair value of common stock issued for services $ 250 47,750 48,000
Fair value of common stock issued for services, shares 250,000      
Fair value of common stock issued as compensation
Net loss (2,139,000) (2,139,000)
Ending balance, value at Jun. 30, 2025 $ 519,216 134,511,784 (139,113,000) (4,082,000)
Ending balance, shares at Jun. 30, 2025 519,215,177      
Beginning balance, value at Dec. 31, 2025 $ 543,351 136,182,649 (142,605,000) (5,879,000)
Beginning balance, shares at Dec. 31, 2025 543,350,596      
Common stock issued on conversion of notes payable $ 2,734 220,266 223,000
Common stock issued on conversion of notes payable, shares 2,733,513      
Relative fair value of warrants issued with convertible notes
Common stock issued upon exercise of stock options and warrants $ 14,072 1,327,928 1,342,000
Common stock issued upon exercise of stock options and warrants, shares 14,071,747      
Common stock issued upon cashless exercise of warrants to settle vendor payables $ 200 24,800 25,000
Common stock issued upon cashless exercise of warrants to settle vendor payables, shares 199,998      
Fair value of vested stock options issued for services 765,000 765,000
Fair value of vested warrants issued for services 463,000 463,000
Fair value of vest stock options issued to officers and directors 62,000 62,000
Stock-based compensation expense – warrant modification 25,000 25,000
Fair value of common stock issued for services $ 4,200 415,800 420,000
Fair value of common stock issued for services, shares 4,200,000      
Net loss (2,944,000) (2,944,000)
Ending balance, value at Jun. 30, 2026 $ 564,557 139,486,443 (145,549,000) (5,498,000)
Ending balance, shares at Jun. 30, 2026 564,555,854      
Beginning balance, value at Mar. 31, 2026 $ 550,786 137,049,214 (143,386,000) (5,789,000)
Beginning balance, shares at Mar. 31, 2026 550,786,275      
Common stock issued on conversion of notes payable $ 285 36,715 37,000
Common stock issued on conversion of notes payable, shares 284,355      
Relative fair value of warrants issued with convertible notes
Common stock issued upon exercise of stock options and warrants $ 9,119 837,881 847,000
Common stock issued upon exercise of stock options and warrants, shares 9,118,559      
Common stock issued upon cashless exercise of warrants to settle vendor payables $ 167 19,833 20,000
Common stock issued upon cashless exercise of warrants to settle vendor payables, shares 166,665      
Fair value of vested stock options and warrants 993,000 993,000
Fair value of vest stock options issued to officers and directors 112,000 112,000
Stock-based compensation expense – warrant modification 25,000 25,000
Fair value of common stock issued for services $ 4,200 415,800 420,000
Fair value of common stock issued for services, shares 4,200,000      
Net loss     (2,163,000) (2,163,000)
Ending balance, value at Jun. 30, 2026 $ 564,557 $ 139,486,443 $ (145,549,000) $ (5,498,000)
Ending balance, shares at Jun. 30, 2026 564,555,854